Liminatus Pharma, Inc. Class A Common Stock (LIMN) Put/Call Volume History

Put/call volume ratio compares the number of put options traded to call options traded. Extreme readings can signal shifts in market sentiment relative to recent norms.

Liminatus Pharma, Inc. Class A Common Stock (LIMN) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $4.8M, listed on NASDAQ, employing roughly 3 people, carrying a beta of 0.76 to the broader market. Liminatus Pharma, Inc. Led by Chris Kim, public since 2025-05-01.

Put/call volume history tracks trading activity and sentiment over time. No recent options activity for LIMN as of 2026-06-02; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how options volume is reported and how to read the data →